CYDY can't even pay it's payroll, what movement would you say is imminent?? Two trials stopped by the FDA, has no cash to start any new trials, NASH data was mediocre at best relative to the leading NASH development candidates, mTNBC was rejected by FDA, and is under SEC and DOJ investigation, etc.
It is a very grim picture.
News 
Market Data 
Discover 
